These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2141371)

  • 1. [Drug eruption due to iohexol (Omnipaque)].
    Asano S; Ikeda M; Ichikawa E; Okabe S; Kawamura T; Maeda M
    Rinsho Hoshasen; 1990 Apr; 35(4):533-6. PubMed ID: 2141371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical analysis of drug eruption due to iohexol (Omnipaque)].
    Akiyama M; Iijima M; Fujisawa R
    Nihon Hifuka Gakkai Zasshi; 1990 Sep; 100(10):1057-60. PubMed ID: 1702479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug eruption caused by the nonionic contrast medium iohexol. "Recall-like phenomenon" appearing on an area previously affected by herpes zoster.
    Matsumura T; Watanabe H; Batchelor J; Sueki H; Iijima M
    J Dermatol; 2006 Oct; 33(10):705-8. PubMed ID: 17040501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed drug eruption associated with intravenous contrast media: report in a woman receiving iohexol.
    Wright NA; Cohen PR
    J Drugs Dermatol; 2011 Jul; 10(7):802-4. PubMed ID: 21720665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prolonged skin reactions after myelography].
    Wagner A
    Ugeskr Laeger; 1989 Apr; 151(17):1058-9. PubMed ID: 2525294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed hypersensitivity reaction after infusion of nonionic intravenous contrast material for an excretory urogram: a case report and review of the literature.
    Stovsky MD; Seftel AD; Resnick MI
    J Urol; 1995 May; 153(5):1641-3. PubMed ID: 7714996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of iohexol in excretory urography].
    Nagai T; Okamura K; Yokoi K; Ando T; Sahashi M; Miyake K; Kobayashi H; Obata K; Fukatsu H; Segawa A
    Hinyokika Kiyo; 1990 Aug; 36(8):963-7. PubMed ID: 2239603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized seizures following myelography with iohexol (Omnipaque).
    Altschuler EM; Segal R
    J Spinal Disord; 1990 Mar; 3(1):59-61. PubMed ID: 2134411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug eruption caused by nonionic iodinated X-ray contrast media.
    Akiyama M; Nakada T; Sueki H; Fujisawa R; Iijima M
    Acad Radiol; 1998 Apr; 5 Suppl 1():S159-61. PubMed ID: 9561070
    [No Abstract]   [Full Text] [Related]  

  • 10. Myelography with Omnipaque (Iohexol) using basic radiographic facilities: the main adverse effects.
    Ndosi BN; Ndosi NK; Kazema RR
    Cent Afr J Med; 1996 Jul; 42(7):192-5. PubMed ID: 8936782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contrast medium reaction to iohexol (Omnipaque) with monocyte activation demonstrated in vivo].
    Bolz KD; Bolle R; Due J; Osterud B
    Rofo; 1987 Mar; 146(3):347-9. PubMed ID: 3031769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iohexol does not influence the levels of blood serum cation electrolytes during intravenous pyelography.
    Kokkas B; Mironidou M; Katsimba D; Kaitatzis C; Karamanos G; Christopoulos S
    Radiol Med; 2001 Jun; 101(6):485-7. PubMed ID: 11479446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelography using iohexol (Omnipaque).
    Peeters F
    Diagn Imaging Clin Med; 1986; 55(6):348-51. PubMed ID: 3643831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous digital subtraction angiography with iohexol (Omnipaque) and sodium meglumin diatrizoate (Urografin).
    Karle A; Fries J; Laulund S; Andrew E
    Diagn Imaging Clin Med; 1986; 55(6):352-9. PubMed ID: 3545629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Speech disturbance following myelography with iohexol: a case report].
    Hayashi T; Miyazaki H; Toda Y; Ishiyama N; Harada T
    No To Shinkei; 2005 Sep; 57(9):796-9. PubMed ID: 16248368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive skin tests in late reactions to radiographic contrast media.
    Brockow K; Kiehn M; Kleinheinz A; Vieluf D; Ring J
    Allerg Immunol (Paris); 1999 Feb; 31(2):49-51. PubMed ID: 10219427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of cutaneous drug reactions.
    Puavilai S; Timpatanapong P
    J Med Assoc Thai; 1989 Mar; 72(3):167-71. PubMed ID: 2525591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular exanthema appearing 5 days after X-ray contrast medium administration.
    Christiansen C; Dreborg S; Pichler WJ; Ekeli H
    Eur Radiol; 2002 Dec; 12 Suppl 3():S94-7. PubMed ID: 12522613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast medium and patients at risk: asthma.
    Boehm I
    Acta Radiol; 2009 Apr; 50(3):348. PubMed ID: 19234895
    [No Abstract]   [Full Text] [Related]  

  • 20. Low negative predictive value of skin tests in investigating delayed reactions to radio-contrast media.
    Vernassiere C; Trechot P; Commun N; Schmutz JL; Barbaud A
    Contact Dermatitis; 2004 Jun; 50(6):359-66. PubMed ID: 15274727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.